For instance, stromal cells including fibroblasts could mediate resistance to RAF inhibitors in BRAF‐mutant melanoma by secreting HGF and activating MAPK and PI3K signaling pathways in tumor cells.186. This evidence concerns the gene BRAF and melanoma.